DocGo Inc. (NASDAQ:DCGO) Expected to Post Q2 2024 Earnings of $0.06 Per Share

DocGo Inc. (NASDAQ:DCGO) – Stock analysts at Northland Capmk reduced their Q2 2024 earnings estimates for shares of DocGo in a research note issued on Tuesday, April 9th. Northland Capmk analyst M. Latimore now expects that the company will earn $0.06 per share for the quarter, down from their prior estimate of $0.07. The consensus estimate for DocGo’s current full-year earnings is $0.35 per share.

Several other research firms have also recently issued reports on DCGO. Stifel Nicolaus decreased their price objective on DocGo from $11.00 to $8.00 and set a “buy” rating on the stock in a report on Wednesday. Cantor Fitzgerald decreased their price target on DocGo from $13.00 to $11.00 and set an “overweight” rating on the stock in a research note on Thursday, February 29th. BTIG Research lowered their price target on DocGo from $13.00 to $11.00 and set a “buy” rating for the company in a report on Wednesday. Needham & Company LLC cut their price objective on shares of DocGo from $14.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, February 29th. Finally, Canaccord Genuity Group decreased their target price on shares of DocGo from $10.00 to $9.00 and set a “buy” rating on the stock in a research report on Thursday. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $10.83.

DocGo Stock Performance

DCGO stock opened at $3.26 on Friday. The company has a 50 day moving average price of $3.73 and a two-hundred day moving average price of $4.70. The stock has a market capitalization of $339.59 million, a P/E ratio of 46.57, a PEG ratio of 0.34 and a beta of 0.91. DocGo has a one year low of $2.78 and a one year high of $10.82.

DocGo (NASDAQ:DCGO) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.06 earnings per share for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.07). DocGo had a net margin of 1.10% and a return on equity of 2.01%. The firm had revenue of $199.25 million during the quarter, compared to analyst estimates of $195.48 million.

Institutional Investors Weigh In On DocGo

Several institutional investors have recently bought and sold shares of DCGO. AJOVista LLC purchased a new position in shares of DocGo in the 4th quarter valued at $25,000. Federated Hermes Inc. purchased a new position in DocGo in the third quarter valued at about $29,000. Royal Bank of Canada lifted its stake in shares of DocGo by 226.3% during the first quarter. Royal Bank of Canada now owns 3,263 shares of the company’s stock worth $30,000 after purchasing an additional 2,263 shares in the last quarter. Tower Research Capital LLC TRC boosted its position in shares of DocGo by 145.6% in the third quarter. Tower Research Capital LLC TRC now owns 5,908 shares of the company’s stock worth $31,000 after buying an additional 3,502 shares during the period. Finally, Wells Fargo & Company MN grew its stake in shares of DocGo by 320.1% in the fourth quarter. Wells Fargo & Company MN now owns 6,192 shares of the company’s stock valued at $44,000 after buying an additional 4,718 shares in the last quarter. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at DocGo

In other news, Director Michael J. Burdiek acquired 10,000 shares of the business’s stock in a transaction dated Thursday, March 14th. The shares were bought at an average cost of $3.61 per share, for a total transaction of $36,100.00. Following the acquisition, the director now directly owns 571,595 shares in the company, valued at approximately $2,063,457.95. The purchase was disclosed in a filing with the SEC, which is available through this link. 13.78% of the stock is owned by company insiders.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.